ArchiveJuly 2018

Diagnosis: bigger is not always better

When you have a first demyelinating event, you get a scan to see if there are lesions in time (lesions of different age) and space (lesions in different places).  Does it matter how big the scanner is? The simple answer is no.  The conventional scanner has a strenght of 1.5T (essentially showing how well the scanner can magnify the brain image) Newer ones are 3T and are more powerful...

The influence of spinal cord volume loss

Although it is not always done, spinal cord imaging may help to see what is in store for your leg function. Spinal cord volume loss: A marker of disease progression in multiple sclerosis.Tsagkas C, Magon S, Gaetano L, Pezold S, Naegelin Y, Amann M, Stippich C, Cattin P, Wuerfel J, Bieri O, Sprenger T, Kappos L, Parmar K.Neurology. 2018 Jun 27. pii: 10.1212/WNL.0000000000005853. ...

How can we create a prevention study in MS? We need your help!

Many of you will have seen the previous post on Preventive Neurology and the new initiative we are setting up to work towards preventing MS. As many of the comments have identified, this is a difficult area to study. We have to find a way to start monitoring people before they develop the earliest signs of MS.                     If you...

We need feedback on our new listeriosis prevention pack – can you help?

We’ve now developed our listeriosis prevention pack and would like 10 people to test it out and give us feedback to improve it further.        We’ll post a kit to you and would like you to open the pack, read through the information and give us feedback on the context, images, objects in the box and how you get in with it. Why a listeria pack?  Currently...

Stornoway research day series: Diagnosing and treating relapses

Dr Sarah Martin talks about how to define and treat a relapse in multiple sclerosis, for healthcare professionals working on the Western Isles. Watch Sarah’s talk on our Youtube channel. Subscribe to our channel to keep up to date with our talks and videos. This is one of the talks from the healthcare professionals day. The audience consisted of district nurses, physios, health visitors...

Stornoway research day series: Biomarkers in MS

Doc Neuro Gnanapavan discusses biomarkers in multiple sclerosis, to an audience of healthcare workers on the Western Isles. She defines what biomarkers are, and why they are useful for diagnosing and monitoring MS.  Watch Doc Neuro Gnanapavan’s talk on our Youtube channel. Subscribe to our channel to keep up to date with our talks and videos. This is one of the talks from the...

We need your thoughts

The MS Society in the UK is committed to finding treatments for progressive MS, and have ambitious plans to make that happen as quickly as possible. They have been asking the question Which existing drugs could help in progressive MS? Can you help? They want a new clinical trials platform to be fast, efficient and flexible. That means being able to change dosage or the number of participants as...

Remyelination. Is ivermectin the next great thing or something dangerous?

What do Remyelination, Parasites and Collie Dogs have in common? Answer..A response to Ivermectin.  This a drug that is used to kill parasites,such as head lice and parasitic worms and has been used by millions of humans and farm animals. However, before runing off to the pet shop or doctor to get your fix of remyelination agent…please read this. In a new study it is reported that...

How do CD20-depleting antibodies work..To T or Not to T that is the Question.

As soon as rituximab and then ocrelizumab, which are both CD20 depleting antibodies, were shown to influence relapsing MS, implicating B cells as a target for MS. We had a flow of papers indicating that T cells express weak amounts of CD20. This view is trotted out time and time again, if you mention B cells as an issue. These T cells are depleted by rituximab and so the T cell biologists...

Stornoway research day series: Using technology to support an MS service

Iain Trayner runs a technology enabled care (TEC) programme on the Western Isles. They research, source funding and roll out digital technology that supports patient care. Iain discusses how technology can assist in an MS service, particularly in a rural area such as the Western Isles. He outlines a programme of self-monitoring through Florence, a service that reminds you of appointments...

Translate

Categories

Recent Posts

Recent Comments

Archives